Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Brought to you by

Iomai grosses $56mm with Series C financing

01 Apr 2003

Executive Summary

Transcutaneous immunization company Iomai Corp. raised $54mm in its Series C private financing, which was co-led by new investor New Enterprise Associates (NEA) and Essex Woodlands Health Ventures. Also participating were Domain Associates, Technology Partners, MedImmune Ventures (the venture arm of MedImmune Inc.), ProQuest Investments, China Development Industrial Bank, and SAM Sustainability Private Equity.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
      • Transdermal
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies

UsernamePublicRestriction

Register

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By